• Green badge means that the vaccination was received on time. 

• Yellow badge means that the vaccination was received late. 

• Gray badge means that the vaccination was not received.

Please note that the following vaccine doses are required by a child at birth. 

BCG 

The Bacillus Calmette-Guérin (BCG) vaccine is given at birth or shortly after birth, primarily for its benefits in protecting against tuberculosis (TB) and certain severe forms of TB, such as tuberculous meningitis and miliary TB. It may also provide partial protection against leprosy 

Hepatitis B 

The Hepatitis B vaccine is administered within 24 hours of birth to prevent perinatal transmission of the virus, establish long-lasting immunity in infants, and reduce the overall prevalence of Hepatitis B infection in the population. 
 

The following vaccine doses are required by a child at 2 months. 

Rota 1 

The Rotavirus vaccine is given at 2 months to provide early protection against rotavirus, which causes severe diarrhea and related complications in infants. By vaccinating at this age, healthcare providers can significantly reduce the risk of severe illness, hospitalization, and the overall prevalence of rotavirus infection in the population. 

Hexa 1 

Hexavalent vaccines combine multiple vaccines into a single shot, reducing the number of separate injections that infants need to receive. The diseases targeted by Hexavalent vaccine are Diphtheria, Pertussis, Tetanus, Polio, Hepatits B and Haemophilus influenzae type b (Hib), which can cause severe respiratory problems and other complications in infants. Booster doses at later ages are required to maintain protection. 

PCV 1 

The PCV 1 vaccine is administered at 2 months to provide early protection against pneumococcal pneumonia, meningitis, and invasive pneumococcal disease, ultimately improving the overall health and well-being of infants and reducing the prevalence of pneumococcal infections in the population. 
 

The following vaccine doses are required by a child at 6 months.  

PCV 3 

The PCV 3 vaccine is administered at around 4 months of age to provide enhanced and sustained protection against diseases caused by Streptococcus pneumoniae, and prevent severe pneumococcal-related illnesses.   

bOPV 1  

bOPV1 is the first dose in a series of polio vaccines and offers several benefits when given at 6 months. It initiates immunity against poliovirus, and subsequent doses in the series ensure continued protection against polio.  

Penta 1 

Penta1 is the first dose in a series of pentavalent vaccines, which typically include protection against diphtheria, tetanus, pertussis (whooping cough), Haemophilus influenzae type b (Hib), and hepatitis B. 

The following vaccine doses are required by a child at 12 months. 

MMR 1 

MMR1 is given at 12 months to provide early and effective protection against measles, mumps, and rubella, which are serious viral diseases that can lead to complications and outbreaks. This vaccination strategy aims to reduce the risk of infection, protect vulnerable individuals, prevent outbreaks, and improve overall public health by reducing the prevalence of these contagious diseases. 

Varicella 1 

Varicella 1 is given at 12 months to provide protection against chickenpox, a common childhood illness. This vaccination helps prevent chickenpox-related complications, reduce the spread of the virus in the community, and improve overall public health by reducing the prevalence of this contagious disease. 
 

The following vaccine doses are required by a child at 18 months. 

bOPV booster 1 

The bOPV (Bivalent Oral Polio Vaccine) booster 1 administered at 18 months is an important component of polio vaccination efforts. It helps sustain immunity against poliovirus, contributes to global polio eradication efforts, prevents outbreaks, and ensures that children continue to be protected against this infectious and potentially paralyzing disease. 

MMR 2 

MMR2 administered at 18 months provides a second dose of immunity against measles, mumps, and rubella, enhances and extends immunity, prevents outbreaks, and contributes to global efforts to eliminate measles and protect public health. 

DTap 

Tap booster 1 administered at 18 months helps maintain and extend immunity against diphtheria, tetanus, and pertussis, prevents outbreaks, contributes to community immunity, and protects children from these potentially severe and vaccine-preventable diseases. 

IPV 

IPV (Inactivated Polio Vaccine) booster 1 administered at 18 months helps sustain immunity against poliovirus, contributes to global polio eradication efforts, prevents outbreaks, and ensures that children continue to be protected against this infectious and potentially paralyzing disease. 

HiB 

The Hib vaccine administered at 18 months, including booster doses, is essential for maintaining and extending protection against Haemophilus influenzae type b. It helps prevent severe Hib-related diseases, contributes to herd immunity, and ensures that children continue to be protected against this potentially dangerous bacterium as they grow. 
 

The following vaccine doses are required by a child at 5-6 years. 

bOPV booster 2 

The bOPV (Bivalent Oral Polio Vaccine) booster 2 administered at 5-6 years helps sustain immunity against poliovirus, contributes to global polio eradication efforts, prevents outbreaks, and ensures that children continue to be protected against this infectious and potentially paralyzing disease as they enter school age. 

MMR 2 

MMR2 administered at 5-6 years provides a second dose of immunity against measles, mumps, and rubella, enhances and extends immunity, prevents outbreaks, contributes to global efforts to eliminate measles, and protects public health by reducing the prevalence of these contagious diseases. 

Varicella 2 

Varicella 2 administered at 5-6 years provides a second dose of immunity against chickenpox, enhances and extends immunity, prevents severe illness and complications, and contributes to public health by reducing the incidence of chickenpox and related healthcare costs. 

DTaP 

The DTaP booster dose administered at 5-6 years helps reinforce immunity against diphtheria, tetanus, and pertussis, prevents outbreaks, maintains high vaccination coverage rates, and contributes to public health by reducing the prevalence of these contagious and potentially severe diseases. 

IPV 

The IPV (Inactivated Polio Vaccine) booster dose administered at 5-6 years helps reinforce immunity against poliovirus, contributes to global polio eradication efforts, prevents outbreaks, and ensures that children continue to be protected against this infectious and potentially paralyzing disease as they grow older. 
 

The following vaccine doses are required by a child at 13-14 years. 

HPV 1 

HPV 1 (Human Papillomavirus vaccine dose 1) administered at 13-14 years of age is a crucial step in preventing HPV infections and reducing the risk of associated health problems, including certain cancers. It offers long-lasting protection, contributes to herd immunity, and aligns with global efforts to combat HPV-related diseases. 

HPV 2 

HPV 2 (Human Papillomavirus vaccine dose 2) administered at 13-14 years of age complements the first dose (HPV 1) and provides enhanced and long-lasting protection against HPV infections and associated diseases. Completing the two-dose series is an important step in preventing HPV-related cancers and aligns with global efforts to combat HPV-related diseases. 
 

The following vaccine doses are required by a child at 15-18. 

Td/Tdap booster 

The Td or Tdap booster vaccine administered at 15-18 years helps maintain immunity against tetanus, diphtheria, and pertussis, prevents outbreaks, supports herd immunity, and protects both vaccinated individuals and those who are more vulnerable to severe disease. 

Meningococal 

The Meningococal vaccine administered at 15-18 years provides protection against meningococcal diseases (meningitis and bloodstream infections), prevents outbreaks, supports herd immunity, and reduces the risk of severe complications associated with these infections. 
 

• On this page, users can access the details of the selected profile. 

• The journey includes milestones that are represented by images that either reflect an incomplete state of the ongoing vaccination, or a completed image indicating the end of the vaccination process. 

• The completion of the milestones is indicated by checkmarks that represent the doses that have been received. 
 

• When accessing the certificate, users will find their personal information at the top of the page. 

• It also includes detailed information about vaccination records. 

• The columns represent the ages at which vaccinations should be given. 

• The rows represent the names of different vaccinations. 

• A green badge indicates a timely vaccination. 

• A yellow badge indicates a late vaccination. 

• A gray badge indicates that the vaccination was not received. 

• The date of vaccination is displayed below each record of doses given.

• In the "All Missing Vaccines" section, users can view records of all missing vaccine doses. 

• The information displayed includes the age at which the vaccine was supposed to be given. 

• It also includes a "Missing" label, the number of missing doses in parentheses, the image of the stage that indicates the status, and the name and icon of the missing vaccine.

Yes, only the latest vaccination record is displayed here. If the user has not taken a particular vaccination, their details will be marked as "N/A".

• When accessing this page, users will find a comprehensive list of vaccinations. 

• The information provided on this page includes the vaccination name, number of doses, vaccination date, and location